RecruitingNot Applicable

Artificial Intelligence Assists Surgeons' Decision Making

China616 participantsStarted 2021-09-02

Plain-language summary

This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged older than 18 years and younger than 85 years.
✓. Primary rectal adenocarcinoma confirmed by preoperative pathology result.
✓. Expected curative resection via total mesorectal excision procedure.
✓. American Society of Anesthesiologists (ASA) class I, II, or III.
✓. Written informed consent.

Exclusion criteria

✕. Pregnant or breastfeeding women.
✕. Severe mental disorder or language communication disorder.
✕. Hartmann surgery or colostomy is performed intraoperatively.
✕. Interrupted of surgery for more than 30 minutes due to any cause.
✕. Malignant tumors with other organs

What they're measuring

The rate of temporary ileostomy.

Timeframe: Intraoperative period

The morbidity of anastomotic leakage.

Timeframe: 30 days

Trial details

NCT IDNCT04999007

SponsorJichao Qin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09

Contact for this trial

Jichao Qin, MD

+86-27-83665316 jcqin@tjh.tjmu.edu.cn

View on ClinicalTrials.gov More Rectal Cancer trials